Intensity Therapeutics, Inc.
General ticker "INTS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $17.2M (TTM average)
Intensity Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -32.1%.
Estimated limits based on current volatility of 10.2%: low 0.36$, high 0.44$
Factors to consider:
- Total employees count: 16 (-5.9%) as of 2024
- Company does not operate outside North America (retrieved using AI)
- Top business risk factors: Volatile stock price, Operational and conduct risks, Operating losses, Labor/talent shortage/retention, Market competition
- Current price 66.1% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.36$, 4.02$]
- 2025-12-31 to 2026-12-31 estimated range: [1.22$, 3.52$]
Short-term INTS quotes
Long-term INTS plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $7.55MM | $8.32MM | $16.59MM |
| Operating Income | $-7.55MM | $-8.32MM | $-16.59MM |
| Non-Operating Income | $-0.03MM | $-2.22MM | $0.32MM |
| Interest Expense | $0.08MM | $0.30MM | $0.00MM |
| R&D Expense | $5.13MM | $4.79MM | $10.50MM |
| Income(Loss) | $-7.58MM | $-10.54MM | $-16.27MM |
| Profit(Loss)* | $-7.58MM | $-10.54MM | $-16.27MM |
| Stockholders Equity | $-15.10MM | $13.16MM | $2.92MM |
| Assets | $1.76MM | $17.30MM | $4.78MM |
| Operating Cash Flow | $-5.48MM | $-7.21MM | $-15.22MM |
| Investing Cash Flow | $0.00MM | $-6.02MM | $6.35MM |
| Financing Cash Flow | $2.25MM | $20.47MM | $2.90MM |
| Earnings Per Share** | $-0.58 | $-0.77 | $-1.17 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.